156 related articles for article (PubMed ID: 8971180)
1. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice.
Reyes G; Villanueva A; García C; Sancho FJ; Piulats J; Lluís F; Capellá G
Cancer Res; 1996 Dec; 56(24):5713-9. PubMed ID: 8971180
[TBL] [Abstract][Full Text] [Related]
2. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
3. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
[TBL] [Abstract][Full Text] [Related]
4. Stability of ras oncogene mutation in the human tumor xenografts through serial passages.
Kijima H; Abe Y; Yamazaki H; Ohnishi Y; Ueyama Y; Tamaoki N; Nakamura M
Anticancer Res; 1994; 14(6B):2583-7. PubMed ID: 7872685
[TBL] [Abstract][Full Text] [Related]
5. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.
Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G
Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680
[TBL] [Abstract][Full Text] [Related]
6. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
[TBL] [Abstract][Full Text] [Related]
7. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
Sakai Y; Yanagisawa A; Shimada M; Hidaka E; Seki M; Tada Y; Harada T; Saisho H; Kato Y
Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
[TBL] [Abstract][Full Text] [Related]
8. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
[TBL] [Abstract][Full Text] [Related]
9. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
Mueller J; Gansauge S; Mattfeldt T
Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
[TBL] [Abstract][Full Text] [Related]
10. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.
Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN
Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263
[TBL] [Abstract][Full Text] [Related]
11. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
Cui Q; Wang Z; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.
Redston MS; Caldas C; Seymour AB; Hruban RH; da Costa L; Yeo CJ; Kern SE
Cancer Res; 1994 Jun; 54(11):3025-33. PubMed ID: 8187092
[TBL] [Abstract][Full Text] [Related]
13. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.
Moskaluk CA; Hruban RH; Kern SE
Cancer Res; 1997 Jun; 57(11):2140-3. PubMed ID: 9187111
[TBL] [Abstract][Full Text] [Related]
14. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
Aoki K; Yoshida T; Sugimura T; Terada M
Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
16. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
17. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
19. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
20. A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model.
Horiuchi H; Kawamata H; Fujimori T; Kuroda Y
Int J Oncol; 2003 Oct; 23(4):957-63. PubMed ID: 12963974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
